ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology
December 25, 2019The results generated in the U.S. Evoke Pivotal Study demonstrate that the spinal cord response to stimulation can be successfully measured and used to adjust stimulation to maintain spinal cord activation within the patient-specific therapeutic window. -
Saluda Medical announces European Commercial launch of Evoke
September 17, 2019Australia headquartered Saluda Medical Pty Limited has announced the award of CE Mark and the European commercial launch of the Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System for the treatment of chronic pain. -
Saluda Medical announces clinical study results of the chronic pain treatment
June 03, 2019The Evoke and Avalon studies both demonstrated improvements in pain, function, sleep, and quality of life
Pharma Sources Insight January 2025
